{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-143689","form_type":"8-K","ticker":"COGT","cik":"0001622229","company_name":"Cogent Biosciences, Inc.","filed_at":"2022-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.521399+00:00","generated_at":"2026-06-25T23:01:12.721347+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cogent Biosciences terminates $75M ATM equity offering agreement with SVB Securities","bullets":["Terminated Sales Agreement with SVB Securities LLC (f/k/a SVB Leerink) for an at-the-market offering program.","The ATM allowed the company to sell up to $75 million of common stock at its sole discretion.","Termination effective May 5, 2022; the facility is no longer available for use.","Original agreement was entered into on February 8, 2021 and filed as Exhibit 1.2 to the S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-143689","json":"https://secwatch.observer/filing/0001193125-22-143689.json","markdown":"https://secwatch.observer/filing/0001193125-22-143689.md","text":"https://secwatch.observer/filing/0001193125-22-143689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622229/000119312522143689/0001193125-22-143689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622229/000119312522143689/d341370d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:01:12.721347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}